Act Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$9.03 - $21.55 $180,600 - $431,000
-20,000 Closed
0 $0
Q4 2021

Feb 03, 2022
SELL
$20.12 - $35.09 $603,600 - $1.05 Million
-30,000 Reduced 60.0%
20,000 $407,000
Q3 2021

Nov 16, 2021
BUY
$23.84 - $32.03 $190,720 - $256,240
8,000 Added 19.05%
50,000 $1.52 Million
Q2 2021

Aug 16, 2021
BUY
$29.06 - $38.83 $1.22 Million - $1.63 Million
42,000 New
42,000 $1.22 Million

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.81M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email